Management of Herpetic Gingivostomatitis in Children
Disease Severity Assessment and Treatment Algorithm
- The Centers for Disease Control and Prevention recommends oral acyclovir 20 mg/kg per dose (maximum 400 mg/dose) three times daily for 5-10 days for mild to moderate herpetic gingivostomatitis in children, initiated within the first 3 days of symptom onset 1, 2
- Continue therapy until lesions completely heal, as recommended by the Centers for Disease Control and Prevention 1
- Monitor for clinical improvement within 48-72 hours, as suggested by the American Academy of Pediatrics 3
Special Populations and Resistant Cases
- For acyclovir-resistant HSV infection, the Infectious Diseases Society of America recommends foscarnet 40 mg/kg per dose IV three times daily 1, 2, 3
- For neonates with HSV infection, the American Academy of Pediatrics recommends higher doses of IV acyclovir: 20 mg/kg every 8 hours for 14 days (skin/eye/mouth disease) or 21 days (CNS disease) 2, 3
- For neonatal CNS disease, repeat CSF HSV DNA PCR at days 19-21 and do not stop acyclovir until negative, as recommended by the American Academy of Pediatrics 1, 2
Critical Timing Consideration
- Peak viral replication occurs in the first 24 hours after lesion onset, making early treatment imperative, according to the Journal of Clinical Virology 4
Common Pitfalls to Avoid
- Topical antivirals do not reach the site of viral reactivation and cannot impact the host immune response, as reported by the Journal of Clinical Virology 5, 6
- Laboratory confirmation is only needed in immunocompromised patients with atypical presentations, according to the Journal of Clinical Virology 4, 5